In a world where data reigns supreme, you’d think that the National Health Service (NHS) England would have all the answers neatly packaged in a shiny PowerPoint presentation. But alas, it seems that the effectiveness of Palantir, the tech company known for its data analytics prowess, is not as clear-cut as one might hope. In fact, NHS England has come out and admitted that the key data they’ve been relying on doesn’t actually prove that Palantir is doing what it’s supposed to do. Cue the dramatic music.
NHS England later added: “If, in the future, FDP is used for a purpose where the national data opt out does apply, then it will always be respected. This means that the records of patients who have registered a national data opt out will not be processed in the FDP for these purposes.”[130] Therefore, the National Data Opt-Out could be used to limit the information shared with Palantir’s FDP in the future, thereby risking its effectiveness.
Let’s break this down. Palantir, which sounds like something straight out of a sci-fi movie, was brought in to help the NHS with data management. You know, the kind of stuff that helps hospitals run more efficiently, track patient data, and maybe even figure out why your appointment is always running two hours late. But it turns out that the data they’ve been using to measure Palantir’s effectiveness is a bit like trying to measure a fish’s intelligence by how well it can climb a tree. Spoiler alert: it doesn’t work.
So, what exactly happened? Well, NHS England has acknowledged that the key metrics they’ve been using to gauge Palantir’s performance don’t actually correlate to any tangible improvements. It’s like saying, “We’ve got a new car that looks amazing, but we can’t really tell if it drives any better than our old jalopy.” The lack of evidence is raising eyebrows and possibly even a few chuckles in the corridors of power.
Now, you might be wondering how this came to light. It seems that someone, somewhere had the audacity to ask the difficult questions—like, “Hey, does this thing actually work?” And rather than shrugging it off, NHS England decided to take a long, hard look at the data. What they found was a bit underwhelming, to say the least. It’s like when you open a bag of chips, only to find it’s mostly air. Not exactly the crunch you were hoping for.
This revelation has sparked a flurry of discussions and debates across the internet, with some people defending Palantir and others calling for a full-on investigation into its effectiveness. There’s a lot of chatter about whether the NHS should continue to invest in this technology or if it’s time to cut their losses and look for alternatives—like maybe using a good old-fashioned spreadsheet.
Of course, the real question here is: what does this mean for the future of data analytics in healthcare? If the NHS can’t rely on the data they’re getting from Palantir, it raises concerns about how data is being collected, analyzed, and ultimately used to make critical healthcare decisions. We’re talking about lives here, folks. No pressure, right?
In the end, it’s a classic case of ‘don’t believe everything you read’—especially when it comes to data. As NHS England continues to navigate this murky water, we can only hope that they find a solution that works better than a tech company that can’t prove its worth. Let’s keep our fingers crossed that the next time we hear about data in the NHS, it’s not just a bunch of hot air.
Inspired by: “NHS England admits key data does not prove Palantir’s effectiveness” (r/technology)